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Abstract
OBJECTIVE: To elucidate disease-specific molecular changes in osteoarthritis (OA) by analyzing the
differential gene expression profile of damaged vs intact cartilage areas within the same joint of patients
with OA of the knee using a combination of a novel RNA extraction technique and whole-genome
oligonucleotide arrays. METHODS: The transcriptome of macroscopically affected vs intact articular
cartilage as determined by visual assessment was analyzed using an optimized mill-based total RNA
isolation directly from the tissue and high density synthetic oligonucleotide arrays. Articular cartilage
samples were obtained from patients with OA of the knee. Expression of differentially regulated genes
was validated by real-time quantitative polymerase chain reaction and immunohistochemistry.
RESULTS: The amount of RNA obtained by the optimized extraction procedure was at least 1mug per
500mg of cartilage and fulfilled the common quality requirements. After hybridization onto HG-U133
Plus 2.0 GeneChips (Affymetrix), 28.6-51.7% of the probe sets on the microarray showed a detectable
signal above the signal threshold in the individual samples. A subset of 411 transcripts, which appeared
to be differentially expressed, was obtained when applying predefined filtering criteria. Of these, six
genes were found to be up-regulated in the affected cartilage of all patients, including insulin-like
growth factor binding protein 3 (IGFBP-3), wnt-1-inducible signaling protein 1 (WISP-1), aquaporin 1
(AQP-1), delta/notch-like EGF-repeat containing transmembrane (DNER), decay accelerating factor
(DAF), complement factor I (IF). CONCLUSION: The optimized methodical approach reported here
not only allows to determine area-specific gene expression profiles of intraindividually different
low-RNA containing OA cartilage specimens. In addition, this study also revealed novel genes not yet
reported to play a role in the pathophysiology of joint destruction in OA.
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 Abstract 
 
Objective. To elucidate disease-specific molecular changes in osteoarthritis (OA) by 
analyzing the differential gene expression profile of damaged versus intact cartilage 
areas within the same joint of patients with OA of the knee using a combination of a 
novel RNA extraction technique and whole-genome oligonucleotide arrays. 
Methods. The transcriptome of macroscopically affected versus intact articular 
cartilage as determined by visual assessment was analyzed using an optimized mill-
based total RNA isolation directly from the tissue and high density synthetic 
oligonucleotide arrays. Articular cartilage samples were obtained from patients with 
OA of the knee. Expression of differentially regulated genes was validated by real-
time quantitative polymerase chain reaction and immunohistochemistry.  
Results. The amount of RNA obtained by the optimized extraction procedure was at 
least 1 µg per 500 mg of cartilage and fulfilled the common quality requirements. 
After hybridization onto HG-U133 Plus 2.0 GeneChips (Affymetrix), 28.6 to 51.7% of 
the probe sets on the microarray showed a detectable signal above the signal 
threshold in the individual samples. A subset of 411 transcripts, which appeared to be 
differentially expressed, was obtained when applying predefined filtering criteria. Of 
these, six genes were found to be upregulated in the affected cartilage of all patients, 
including IGFBP-3, WISP-1, AQP-1, DNER, DAF and IF.  
Conclusion. The optimized methodical approach reported here not only allows to 
determine area-specific gene expression profiles of intraindividually different low-
RNA containing OA cartilage specimens. In addition, this study also revealed novel 
genes not yet reported to play a role in the pathophysiology of joint destruction in OA. 
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 Abbreviations:  
IGFBP-3: insulin-like growth factor binding protein 3; WISP-1: wnt-1-inducible 
signaling protein 1; AQP-1: aquaporin 1; DNER: delta-notch-like EGF repeat-
containing transmembrane; DAF: decay accelerating factor; IF: complement factor I;  
GAPDH: glyceraldehyde-3-phosphate dehydrogenase; RT-PCR: reverse 
transcription polymerase chain reaction.  
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Introduction 
 
Being the most frequently diagnosed disorder of the muskuloskeletal system 1, 2, 
osteoarthritis (OA) is a multifactorial, slowly progressing and primarily non-
inflammatory degenerative joint disease. It does not only include cartilage alterations 
but also pathological changes in other joint compartments including subchondral 
bone, synovial tissue, the joint capsule, ligaments and periarticular muscles 3, 4. 
 
Owing to the developments in microarray technology, which enabled to draw a more 
concise picture of functional genomics not only in OA, at present, a large variety of 
genes and their products are known to play a role in OA pathophysiology 5-9. 
However, large amounts of pure and intact RNA are necessary when applying array 
techniques, and due to the very low cellular content of cartilage, the extraction of 
RNA from human articular cartilage faces numerous obstacles, specifically with 
regard to an adequate yield for further experiments. This problem often forces 
researchers to isolate cells out of the tissue before extracting the RNA, but leaves the 
problem of potential alteration of gene expression when processing the cells 
unanswered. 
 
Quantitative limitations may also be one of the reasons for the scarcity of data 
addressing alterations in gene expression in distinct areas within the same OA joint, 
especially for the comparison of damaged and intact regions of the cartilage 9-11. In 
these experimental settings, mainly pooled RNA of diseased and healthy cartilage of 
different individuals was used to analyze differential gene expression which could not 
determine disease-specific pathways in a single individual 5-8.  
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Using a novel mill-based RNA isolation technique in combination with high-density 
oligonucleotide array analysis, we investigated the differential gene expression 
pattern of chondrocytes localized within an OA lesion versus an uninvolved part of 
OA cartilage of the same joint on a genome-wide range. We directly processed the 
tissue avoiding an enzymatic tissue digestion, pooling of samples and two-round in 
vitro transcription amplification. Validation of our microarray results was performed by 
real-time quantitative polymerase chain reaction and immunohistochemistry. 
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Patients, Materials and Methods 
Tissue preparation. Cartilage samples were obtained from complete knee joint 
explants from patients with OA undergoing routine total joint replacement surgery. 
The study had been approved by the local Ethics Committees and specimens were 
taken with patients’ written consent. Samples were either used for microarray 
analysis (1 male age 64, and 4 female patients age 59, 71, 73 and 83), validation 
experiments by quantitative PCR (1 male age 55, and 4 females age 65, 73, 76 and 
83) or immunohistochemistry (1 male age 61, and 2 females age 73 and 78). Prior to 
RNA isolation, cartilage tissue was first classified macroscopically as either damaged 
or intact according to a predefined procedure comprising color, surface integrity and 
tactile impression tested with a standard scalpel. Accordingly, diseased areas 
showed a coloration that was rather yellow than white. They showed erosions and 
discrete protuberances that rendered it impossible to smoothly move the scalpel over 
the tissue surface. In unaffected regions there was a stronger resistance when 
cutting deeper into the tissue with the blade of the scalpel, which could not be done 
in the softened lesional areas. Cartilage was rinsed with saline and then dissected 
from the joint explant surfaces. Care was taken to avoid contamination by blood, 
bone or synovium. The tissue was cut into small pieces, immediately snap frozen and 
stored at -80°C until further use. For later histological examination, representative 
pieces of every region were embedded in Tissue-Tek, frozen in liquid nitrogen and 
also stored at –80°C until further use. 
 
RNA extraction. To optimize RNA extraction, we evaluated different mechanical 
tissue disruption strategies including mortar and pestle, a stator-rotor homogenizer 
such as the polytron, a freezer mill and a microdismembrator. We also evaluated 
different isolation procedures including the Trizol method and silica membrane-based 
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commercial extraction kits such as the RNeasy spin columns (Qiagen, Hilden 
Germany) or glass fiber filters (Ambion, Austin, TX, USA). The optimal protocol 
consisted of pulverization of frozen tissue samples at 2500 rpm for 2 minutes under 
continuous cryoconditions (below -18 °C) with a steel ball in steel cases (both pre-
cooled in liquid nitrogen for several minutes) using a swing mill, the 
microdismembrator (Mikrodismembrator S, Braun, Melsungen, Germany; Figure 1). 
Thereafter, a commercial extraction kit (RNAqueous-MidiTM, Ambion) was used to 
isolate total RNA from the resulting cartilage powder. The isolation procedure was 
adapted to the very low RNA containing OA cartilage tissue conditions by modifying 
the manufacturer’s protocol as follows.  
Initially, 6.5 ml of lysis solution containing guanidinium isothiocyanate (GITC) were 
added to 500 mg of freshly milled cartilage that had been transferred to 50 ml 
reaction tubes, which were also pre-cooled in liquid nitrogen. The suspension was 
then mixed by strongly shaking the tube up and down until complete homogenization 
was achieved. Thereafter, the suspension was incubated at 4 °C over night. 
Afterwards, the lysate was centrifuged at 5000 g and 4 °C for 10 minutes. The clear 
supernatant was transferred to a fresh tube of equal size by passing the solution 
through a 70 µm nylon cell filter in order to completely eliminate the rest of debris and 
to prevent glass fiber filter clogging. The procedure was completed then as indicated 
in the instruction manual (Ambion). 
After recovery of the RNA, standard ethanol precipitation and DNase digestion were 
applied: 0.1 volume of 5 M ammonium acetate, 0.01 volume of Glycoblue (both 
Ambion, Austin, TX, USA) and two volumes of ice-cold 100 % ethanol were added to 
the eluates. After gentle mixing, they were incubated at –20°C overnight and then 
centrifuged at 12100 g for 15 minutes using a miniSpin table centifuge (Eppendorf, 
Germany) to pellet the precipitated RNA. After washing the pellet with ice-cold 70 % 
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(v/v) ethanol it was resolved in the respective volume of nuclease-free water pre-
heated to 65°C, usually 10 to 20 µl. DNase digestion was performed according to the 
manufacturer’s instructions using the TURBO DNA-freeTM Kit (Ambion).  
RNA yields were quantified spectrophotometrically measuring its absorbance (A) at a 
wavelength of 260 nm. Qualitative assessment of RNA integrity was performed by 
taking the A260/280 ratio as well as doing RNA 6000 Nano Assays on an Agilent 2100 
Bioanalyzer (Agilent Technologies), respectively. During the evaluation phase, RNA 
quality was also analyzed on 0.8 % denaturating agarose gels containing 
formaldehyde. 
 
High-density synthetic oligonucleotide array hybridization. The individual 
chondrocyte RNA samples were used to synthesize cDNA that was in vitro 
transcribed into biotin-labeled cRNA. Fragmented cRNA was then hybridized to 
microarrays (Affymetrix® HG-U133 Plus 2.0 Arrays, Center of Excellence for 
Fluorescent Bioanalysis, Regensburg, Germany) following standard Affymetrix 
protocols using the MessageAmpTM II-Biotin Enhanced Kit (Ambion). Finally, 15 µg of 
the fragmented cRNA was hybridized to the GeneChips, washed and stained with the 
streptavidin-phycoerythrin complex. Signal intensity images were acquired by 
scanning the arrays with a GeneChip Scanner 3000 following standard protocols 
(Affymetrix). 
 
Data analysis. Low-level analysis including background correction and qualitative 
experiment evaluation by checking internal controls as well as calculating expression 
values for all genes on all arrays were performed using the GeneChip Operating 
Software 1.2 with its MAS5 algorithm (Affymetrix). The arrays were normalized by 
global scaling the mean array intensities to a target intensity value of 100. Lesional 
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chondrocyte gene expression arrays were compared to their corresponding baseline 
arrays of non-lesional regions in order to obtain a patient-specific pairwise “chip-by-
chip” analysis of differential gene expression. Using MS Excel for the identification of 
genes of interest, we then focused on all transcripts that were regulated in the same 
direction (up- or downregulated) according to their change calls for increase (I) or 
decrease (D) in at least 3 of the 5 patients and that did not show nonsense detection 
calls. Therefore, genes had to be called as present in at least baseline or experiment 
array, and up-regulated genes showing absent calls in the experiment array as well 
as down-regulated genes called absent in the baseline array had to be excluded 12. 
The statistical algorithms for calculating these parameters, i.e. change calls and 
detection calls, as well as to indicate signal log ratios, were applied according to the 
software manual descriptions 13. A signal log ratio is defined as the dyadic logarithm 
of a fold change. 
 
Real-time quantitative PCR. Gene expression results of those genes found to be 
up-regulated in all 5 patients were validated by real-time quantitative PCR, applying 
the ∆∆Ct relative quantification method and using GAPDH as an internal control. 
Purified RNA was reversely transcribed into cDNA using Superscript II RT 
(Invitrogen, Karlsruhe, Germany). Equivalent amounts as calculated by the initial 
RNA quantity were added to the reaction mix including 12.5 µl SYBR Green (Applied 
Biosystems), forward and reverse primer (10 pmol/µl), 0.5 µl each (MWG-Biotech, 
Ebersberg, Germany) and nuclease-free water to final volumes of 25 µl per well. 
Primer sequences are listed in Table 1. Real-time polymerase chain reactions were 
run in an ABI Prism 7000 Sequence Detection System (SDS) using the ABI Prism 
7000 SDS software version 1.2.3. 
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Immunohistochemistry. Ice-cold acetone-fixed cryosections (5 µm) were used to 
perform immunohistochemistry. Sections were first blocked with 5 % low-fat milk for 
60 minutes at room temperature followed by incubation with the primary antibodies 
(goat polyclonal anti-WISP-1, 1:5 dilution, R&D Systems, goat polyclonal anti-DAF, 
1:40 dilution, R&D Systems, or mouse monoclonal anti-AQP-1 antibodies, 1:100 
dilution, Biozol, Eching, Germany), followed by peroxidase blocking with 0.6 % H2O2 
in methanol for 30 minutes at 4 °C. Immunoreactivity was detected using labeled 
polymers prepared by combining amino acid polymers with peroxidase and 
secondary antibodies reduced to Fab’ fragments (N-Histofine simple Stain MAX PO 
(G) anti-goat and MAX PO (MULTI) anti-mouse) for 30 minutes at room temperature, 
followed by color development using 3-amino-9-ethylcarbazole substrate (AEC 
substrate kit, Axxora, San Diego, CA, USA). The sections were counterstained with 
Meyer’s hematoxylin for 10 minutes and then mounted with Aquatex (Merck, 
Darmstadt, Germany). Negative controls were obtained by omitting the primary 
antibodies or by incubating the tissue sections with irrelevant isotype-matched normal 
IgG (goat: Santa Cruz Biotechnology, Heidelberg, Germany; mouse: BD Pharmingen, 
Heidelberg, Germany). Sections were examined under a light microscope and 
photographed with a digital camera. 
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Results 
 
Amounts of total RNA and integrity. Using the adapted and optimized RNA 
isolation procedure, stable amounts of total RNA of at least 1µg per 500 mg OA 
cartilage could be obtained. However, it could be more total RNA depending on the 
quality of the tissue specimen. The A260/280 ratio resulted in values between 1.6 and 
2.0, indicating the lack of a relevant contamination in the samples. Graphical analysis 
on the Agilent Bioanalyzer constantly showed clearly visible peaks for both 28S and 
18S ribosomal RNA demonstrating that RNA degradation during the downstream 
applications was minimal. A representative electropherogram is given in Figure 2. 
Table 2 summarizes the results of different RNA isolation approaches that have been 
evaluated during the optimization process. Among these, different mechanical tissue 
disruption strategies comprising a rotor-stator homogenizer such as the polytron, a 
common mortar and pestle and a swing mill (microdismembrator) were used and 
compared. The RNA isolation was performed using the Trizol method, all available 
package sizes of Qiagen’s RNeasy spin columns ranging from mini over midi to maxi, 
and finally Ambion’s glass filter membranes, also provided in different package sizes. 
RNA of same amounts of tissue was isolated and yields after isolation were 
compared. 
Pretreatment with the polytron and in the microdismembrator was done in lysis buffer 
at room temperature. So far, it was impossible to homogenize the tissue. Disruptions 
with mortar and pestle and again within the microdismembrator were performed 
under cryoconditions using liquid nitrogen. It became clear that the mechanical 
properties of articular cartilage made it necessary to use a closed system to disrupt 
the tissue with stronger forces in its frozen form, which resulted in higher amounts of 
total RNA with integrity, independent of the RNA isolation strategy itself. However, 
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the membrane-based methods (Qiagen and Ambion kits) were superior to the 
common and widely used Trizol method where the RNA was degraded. As the swing 
mill obtained the best pretreatment results, the RNA extraction was compared using 
the Qiagen and Ambion kits. The Ambion kit resulted in the highest amounts of good-
quality RNA. For tissue RNA isolation, especially human articular cartilage, 
combination and evaluation of different options resulted in definite differences with 
regard to the amount and quality of total RNA obtained by these approaches. Of 
note, we did not observe any of the differences described herein when working with 
cells.  
 
Microarray results and differentially expressed genes. In general, between 28.6% 
and 51.7% of the 54675 probe sets on the oligonucleotide array were detectable, 
with an average of 43% (median 47.7%). In the intact areas, an average of 43.1% 
(median 49,8%) versus an average of 42,9% (median 45,6%) in the affected regions 
could be detected. 
 
According to the criteria outlined above, we found 462 Probe Sets for 411 transcripts, 
342 of which could be considered as known genes. Of these, 6 genes were up-
regulated in all 5 patients in the diseased areas, 36 genes in 4 of, and 159 genes in 3 
of the 5 patients. Interestingly, no gene was found to be down-regulated in diseased 
cartilage of all 5 patients, however, 14 genes were down-regulated in 4/5 patients  
and 127 genes in 3/5 patients.  
 
The genes identified to be up-regulated in all 5 patients were insulin-like growth factor 
binding protein 3 (IGFBP-3), wnt-1 inducible signaling protein 1 (WISP-1), aquaporin 
1 (AQP-1), delta/notch-like EGF-repeat containing transmembrane (DNER), decay 
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accelerating factor (DAF, CD55) and complement factor I (I factor for complement, 
IF). Affymetrix probe set IDs, names, short names, the mean signal log ratio and the 
mean change p-value of the 6 genes found to be up-regulated in all 5 patients are 
listed in Table 3. 
 
Results by real-time quantitative PCR. 
Real-time quantitative PCR was performed on the 6 up-regulated genes in order to 
validate the microarray results. We used the RNA of five additional pairs of affected 
and intact cartilage tissue specimens to determine whether there were any 
differences between both techniques. We found that consistent with the microarray 
data, expression of the genes was significantly different between both regions. 
Representative results of one patient are given in Figure 3, which also demonstrates 
that the x-fold change in gene expression monitored by quantitative PCR was higher 
than that obtained by using the microarrays. 
 
Immunohistochemistry. 
To confirm the up-regulation of the genes found in the oligonucleotide array in 
lesional areas in OA cartilage on a protein level, immunohistochemistry was 
performed using commercially available antibodies against AQP-1, WISP-1 and DAF. 
As demonstrated in Figure 4, the increased expression of AQP-1 in damaged tissue 
was restricted to chondrocytes in the superficial areas (Figure 4 E) whereas WISP-1 
was increasingly expressed by chondrocytes throughout the affected cartilage 
(Figures 4 I and K). The increased staining against DAF occuring in the affected 
areas compared to intact cartilage also tended to be more prominent at the 
superficial site of the cartilage (Figures 4 N and O).  
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DISCUSSION 
 
OA is regarded a very complex and multifactorial disease 14, which is based on a 
variety of dysregulated pathways. However, its pathogenesis still needs to be 
elucidated in detail, especially when focusing on the molecular level. For the 
investigation of its complex pathophysiology, articular cartilage containing the key 
cells in the pathophysiology of OA, the chondrocytes, appears to be a perfect type of 
biological material because of its availability from routine joint replacement surgery. 
 
However, the extraction of RNA out of cartilage is still a challenge for all researchers 
working in that field due to its distinct composition. With only between 1-5% of the 
tissue volume, cartilage has a very low cellular content of chondrocytes surrounded 
by a very large amount of extracellular matrix. The matrix itself contains large and 
negatively charged macromolecules, which interfere significantly with the RNA 
extraction process. In the current literature, only a small number of publications exists 
that address how to potentially overcome this specific problem of RNA isolation out of 
cartilage by means of a suitable technical approach. Most of these studies were 
performed on the basis of animal tissues, i.e. of chicks 15, rats 16, dogs 17 or rabbits 18, 
which in general have a higher cellular content than the corresponding human 
tissues, even more when working with immature animals. Only few, single 
publications provide data performed with human samples 19-21. The key problem in 
this setting is the difficulty to isolate sufficient amounts of high-quality RNA that can 
be used for a genome-wide transcription profiling with high-density synthetic 
oligonucleotide arrays as close as possible to the in vivo situation. In addition, as the 
quality of tissue samples differs between individuals, the respective tissue specimens 
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can often not be used for the extraction of RNA despite a minimum of delay between 
surgery and the use in the laboratory. 
 
Thus, the aim of this study was to establish a novel approach to improve the quality 
of RNA extraction and to use this approach to identify novel molecules potentially 
involved in the pathophysiology of human OA. The RNA isolation technique 
immediately after surgery consisted of pre-treating the freshly frozen cartilage 
samples by pulverizing them with a steel ball in steel cases fixed in a swing mill 
followed by the isolation of RNA according to an adapted procedure based on a 
commercial RNA extraction kit. Using our optimized procedure, we were able to 
isolate the RNA of chondrocytes with satisfying high yield and quality. Subsequently, 
we were able to investigate the differential gene expression of lesional and intact 
zones of native human OA cartilage, avoiding the difficulties of the interpretation of 
gene array data generated by pooling samples of different genetic background. 
 
Validation of our results was facilitated by quantitative polymerase chain reaction as 
well as by examination of the corresponding proteins in other OA samples by 
immunohistochemistry. Applying this strategy, several novel genes hitherto not 
known to be involved in the pathogenesis of OA were identified. In total, 201 genes 
were found to be up-regulated within the lesional areas of OA cartilage versus 141 
genes considered to be down-regulated when filtering the gene expression data 
according to the abovementioned criteria. Only 6 genes were found to be up-
regulated within the lesional area of all examined patients but not in non-lesional 
cartilage. Particularly, WISP-1 and AQP-1 have not been previously linked to the 
imbalance of damage and repair in OA, whereas IGFBP-3 and DAF have been 
reported earlier (see the references under discussion). 
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 IGFBP-3 (Insulin-like growth factor binding protein 3) is a binding protein for IGFs 
(insulin-like growth factors). The expression of IGFBP-3 has been reported to be 
increased in OA when compared to healthy cartilage 22. It has been stated that 
IGFBP-3 may inhibit growth by binding local IGF-I 23. IGFBPs maintain local 
availability of IGF. IGFBP-3 was also found to form a complex together with 
fibronectin and to retain IGF-I in the perichondrocytic matrix 24. Thus, locally 
produced IGFBPs appear to act as autocrine and/or paracrine regulators of IGF 
activity both in a positive and negative manner. Moreover, the increased production 
of IGFBP-3 may not only be explained by the influence of fibronectin fragments 25, 
but also by inflammatory cytokines such as IL-1 and TNF-α 26 as well as by 
prostaglandin E2 27 which also can up-regulate IGFBP-3. Most interestingly, binding 
of IGF-I to IGFBP-3 was successfully inhibited by NBI-31772 in rabbit and human 
chondrocytes in vitro, resulting in restoration of proteoglycan synthesis 28. IGFBP-3 
might therefore be a target for a pharmacological intervention in OA, although NBI-
31772 itself is not able to penetrate into the matrix of the explanted cartilage samples 
28. 
 
WISP-1 (wnt-1 inducible signaling pathway protein 1) is a member of the CCN family 
of growth factors 29. With regard to the musculoskeletal system, WISP-1 exerts an 
important contribution to bone development. French et al. could show that WISP-1 
functions as an osteogenesis potentiating factor promoting mesenchymal cell 
proliferation while repressing chondrocytic differentiation in vitro 30. This property 
could also be demonstrated in fracture healing in a mouse fracture repair model 30. In 
2006, the expression of full-length WISP-1 mRNA as well as of two variants were 
reported in a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8 31. The 
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role of WISP-1 in chondrocyte differentiation appeared to be more specific to the 
mineralizing stage of enchondral ossification 31. Taking into account that WISP-1 is 
also expressed by OA chondrocytes in vivo as outlined above, the data suggest that 
WISP-1 might be involved in the ossification of cartilage contributing to the formation 
of a local osteopetrosis and bony osteophytes. 
 
AQP-1 (aquaporin 1) is a 28 kDa water channel formed by six transmembrane 
domains with N- and C-terminus at the inner cytosolic site of the cell membrane 32. 
Aquaporins are involved in many physiological processes, in which the homeostasis 
of water content is essential. In contrast, dysregulation and/or clearance of water can 
become a critical factor as seen in different human diseases. AQP-1 itself was 
reported to be selectively down-regulated in salivary glands in primary Sjögren’s 
syndrome 33. With respect to joint physiology, AQP-1 was previously described to be 
expressed in articular cartilage when a systematic investigation of AQP-1 expression 
in normal human tissues using tissue microarray technology was performed 34. 
Specifically, a moderate expression of AQP-1 was observed, which was limited to the 
deeper zone of articular cartilage adjacent to the subchondral bone. Most 
interestingly, as demonstrated in our experiments, expression of the AQP-1 in OA is 
not restricted to the deeper zone. Increased staining was also seen towards the 
surface and even more prominent at the sites of superficial damage compared to 
unaffected cartilage sections. Expression of AQP-1 in cartilage might depend on the 
underlying disease. In RA, AQP-1 could be restricted to chondrocytes located in the 
deep zone of articular cartilage, but was also suggested to be found in synoviocytes 
and in synovial microvasculature 35. In summary, it can be speculated that the 
expression of AQP-1 contributes to the altering of the water-dependent homeostasis 
of cells and matrix, a key process in the pathophysiology of early OA. 
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 At present, there are no data addressing the role of DNER (delta/notch-like EGF-
repeat containing transmembrane) in OA. DNER is a transmembrane protein 
expressed specifically in cells of the developing and mature central nervous system 
36. Interestingly, DNER binds to Notch-1 at cell-cell contacts and activates Notch 
signaling in vitro. It is well established that notch family proteins control cell fate and 
proliferation 37. In another murine model, Notch-1 was involved in the complex 
interactions during ossification and elongation of the growth plate, in which Notch-1 
was restricted to hypertrophic chondrocytes 38. This work also revealed the 
expression of Notch-1 by murine articular cartilage, in which its signaling was 
suggested to determine the proliferation of chondrocytes. As EGF domains represent 
an important role in the function of cartilage proteoglycans, DNER might contribute to 
the insufficient attempt of matrix remodeling in OA. 
 
DAF (decay accelerating factor) and IF (I factor, conglutinogen-activating factor), 
belong to the complement system. DAF, also known as CD55, is a regulatory cell 
surface protein that protects cells from complement-mediated lysis. It can bind C3b 
and C4b and dissociate the C3 convertase of both the classical and alternative 
pathway 39. Aside CD46 and CD59, DAF was found to be expressed in diseased 
cartilage from arthritic human and porcine joints and to be up-regulated when 
compared to normal cartilage 40. It was hypothesized that complement regulatory 
proteins may contribute to ameliorate the damaging effects seen in joint destruction 
40. However, DAF is expressed in the synovial lining layer in both RA and OA as well 
as on synovial vascular endothelial cells 41.  
So far, no data exist about the complement C3b inactivator IF in OA. Unlike DAF, it 
appears not membrane-associated.  
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 Apart from the genes up-regulated in all five patients and discussed above, it is also 
of interest that in 4/5 patients an up-regulation of collagen type I was observed, since 
collagen type I was one of the first described matrix molecules to be induced in 
human osteoarthritic cartilages 42. Together with periostin, which might contribute to 
the formation of bony osteophytes and which was also reported to play a major role 
in improving the cardiac function after myocardial infarction by inducing proliferation 
of differentiated cardiomyocytes 43, the results once more indicate the attempt of the 
chondrocytes to remodel their extracellular matrix.   
 
In summary, we established a novel approach to identify genes expressed 
differentially between intact and damaged articular cartilages of the same joint in OA 
patients. This approach is based on an improved novel mill-based method for the 
isolation of sufficient amounts of high-quality RNA suitable for use in high-density 
microarray technology. In this regard, we were able to perform whole-transcriptome 
screens by using a chip type comprising probe sets for approximately 47400 
transcripts and variants, of which 38500 are well characterized genes. Compared to 
previously published work 9, our hybridization data contain an additional number of 
9921 probe sets for 6500 new genes not detectable by earlier chip versions. Of the 
411 transcripts found to be differentially expressed, we could identify 6 genes that 
were up-regulated in all patients. Of these, specifically WISP-1, AQP-1 and DNER 
could be identified as novel target molecules and potential biomarkers 44 involved in 
the pathogenesis of OA.  
 
ACKNOWLEDGEMENTS 
The authors appreciate the excellent technical assistance of Simone Kistella.  
 21
This study was supported by the Deutsche Forschungsgemeinschaft (DFG Mu 
1383/3-2 and Mu 1383/3-3, Research Unit FOR696, and DFG Gr 1301/4-3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 1.  Reginster JY. The prevalence and burden of arthritis. Rheumatology (Oxford) 
2002; 41 Supp 1:3-6. 
 2.  Reginster JY, Khaltaev NG. Introduction and WHO perspective on the global 
burden of musculoskeletal conditions. Rheumatology (Oxford) 2002; 41 Supp 
1:1-2. 
 3.  Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al. 
Development of criteria for the classification and reporting of osteoarthritis. 
Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria 
Committee of the American Rheumatism Association. Arthritis Rheum 1986; 
29(8):1039-49. 
 4.  Mankin HJ, Brandt KD, Shulman LE. Workshop on ethiopathogenesis of 
osteoarthritis - proceedings and recommendations. J Rheumatol 1986; 
13:1127-60. 
 5.  Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and 
catabolic gene expression pattern analysis in normal versus osteoarthritic 
cartilage using complementary DNA-array technology. Arthritis Rheum 2001; 
44(12):2777-89. 
 6.  Aigner T, Zien A, Hanisch D, Zimmer R. Gene expression in chondrocytes 
assessed with use of microarrays. J Bone Joint Surg Am 2003; 85-A Suppl 
2:117-23. 
 7.  Aigner T, Saas J, Zien A, Zimmer R, Gebhard PM, Knorr T. Analysis of 
differential gene expression in healthy and osteoarthritic cartilage and isolated 
chondrocytes by microarray analysis. Methods Mol Med 2004; 100:109-28. 
 22
 8.  Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T et al. Large-scale 
gene expression profiling reveals major pathogenetic pathways of cartilage 
degeneration in osteoarthritis. Arthritis Rheum 2006; 54(11):3533-44. 
 9.  Sato T, Konomi K, Yamasaki S, Aratani S, Tsuchimochi K, Yokouchi M et al. 
Comparative analysis of gene expression profiles in intact and damaged 
regions of human osteoarthritic cartilage. Arthritis Rheum 2006; 54(3):808-17. 
 10.  Yagi R, McBurney D, Laverty D, Weiner S, Horton WE, Jr. Intrajoint 
comparisons of gene expression patterns in human osteoarthritis suggest a 
change in chondrocyte phenotype. J Orthop Res 2005; 23(5):1128-38. 
 11.  Fukui N, Ikeda Y, Ohnuki T, Tanaka N, Hikita A, Mitomi H et al. Regional 
differences in chondrocyte metabolism in osteoarthritis: A detailed analysis by 
laser capture microdissection. Arthritis Rheum 2007; 58(1):154-63. 
 12.  Affymetrix Inc. GeneChip expression analysis: Data analysis fundamentals.  
2002. http://www.affymetrix.com 
 
 13.  Affymetrix Inc. Statistical algorithms reference guide. 2001. 
http://www.affymetrix.com 
 
   14.  Krasnokutsky S, Samuels J, Abramson SB. Osteoarthritis in 2007. Bulletin of 
the NYU Hospital for Joint Diseases 2007; 65(3):222-8. 
 15.  Leboy PS, Shapiro IM, Uschmann BD, Oshima O, Lin D. Gene expression in 
mineralizing chick epiphyseal cartilage. J Biol Chem 1988; 263(17):8515-20. 
 16.  Nemeth GG, Heydemann A, Bolander ME. Isolation and analysis of 
ribonucleic acids from skeletal tissues. Anal Biochem 1989; 183(2):301-4. 
 17.  Adams ME, Huang DQ, Yao LY, Sandell LJ. Extraction and isolation of mRNA 
from adult articular cartilage. Anal Biochem 1992; 202(1):89-95. 
 18.  Reno C, Marchuk L, Sciore P, Frank CB, Hart DA. Rapid isolation of total RNA 
from small samples of hypocellular, dense connective tissues. Biotechniques 
1997; 22(6):1082-6. 
 19.  McKenna LA, Gehrsitz A, Soder S, Eger W, Kirchner T, Aigner T. Effective 
isolation of high-quality total RNA from human adult articular cartilage. Anal 
Biochem 2000; 286(1):80-5. 
 20.  Mallein-Gerin F, Gouttenoire J. RNA extraction from cartilage. Methods Mol 
Med 2004; 100:101-4. 
 21.  Gehrsitz A, McKenna LA, Soder S, Kirchner T, Aigner T. Isolation of RNA from 
small human articular cartilage specimens allows quantification of mRNA 
expression levels in local articular cartilage defects. J Orthop Res 2001; 
19(3):478-81. 
 22.  Iwanaga H, Matsumoto T, Enomoto H, Okano K, Hishikawa Y, Shindo H et al. 
Enhanced expression of insulin-like growth factor-binding proteins in human 
 23
osteoarthritic cartilage detected by immunohistochemistry and in situ 
hybridization. Osteoarthritis Cartilage 2005; 13(5):439-48. 
 23.  Martin JL, Baxter RC. Insulin-like growth factor-binding protein from human 
plasma. Purification and characterization. J Biol Chem 1986; 261(19):8754-60. 
 24.  Martin JA, Miller BA, Scherb MB, Lembke LA, Buckwalter JA. Co-localization 
of insulin-like growth factor binding protein 3 and fibronectin in human articular 
cartilage. Osteoarthritis Cartilage 2002; 10(7):556-63. 
 25.  Purple CR, Untermann TG, Pichika R, Homandberg GA. Fibronectin 
fragments upregulate insulin-like growth factor binding proteins in 
chondrocytes. Osteoarthritis Cartilage 2002; 10(9):734-46. 
 26.  Olney RC, Wilson DM, Mohtai M, Fielder PJ, Smith RL. Interleukin-1 and 
tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-
3 (IGFBP-3) production and IGFBP-3 protease activity in human articular 
chondrocytes. J Endocrinol 1995; 146(2):279-86. 
 27.  DiBattista JA, Dore S, Morin N, Abribat T. Prostaglandin E2 up-regulates 
insulin-like growth factor binding protein-3 expression and synthesis in human 
articular chondrocytes by a c-AMP-independent pathway: role of calcium and 
protein kinase A and C. J Cell Biochem 1996; 63(3):320-33. 
 28.  De Ceuninck F, Caliez A, Dassencourt L, Anract P, Renard P. 
Pharmacological disruption of insulin-like growth factor 1 binding to IGF-
binding proteins restores anabolic responses in human osteoarthritic 
chondrocytes. Arthritis Res Ther 2004; 6(5):R393-403. 
 29.  Brigstock DR. The CCN family: a new stimulus package. J Endocrinol 2003; 
178(2):169-75. 
 30.  French DM, Kaul RJ, D'Souza AL, Crowley CW, Bao M, Frantz GD et al. 
WISP-1 is an osteoblastic regulator expressed during skeletal development 
and fracture repair. Am J Pathol 2004; 165(3):855-67. 
 31.  Yanagita T, Kubota S, Kawaki H, Kawata K, Kondo S, Takano-Yamamoto T et 
al. Expression and physiological role of CCN4/Wnt-induced secreted protein 1 
mRNA splicing variants in chondrocytes. FEBS J 2007; 274(7):1655-65. 
 32.  Borgnia M, Nielsen S, Engel A, Agre P. Cellular and molecular biology of the 
aquaporin water channels. Annu Rev Biochem 1999; 68:425-58. 
 33.  Beroukas D, Hiscock J, Gannon BJ, Jonsson R, Gordon TP, Waterman SA. 
Selective down-regulation of aquaporin-1 in salivary glands in primary 
Sjogren's syndrome. Lab Invest 2002; 82(11):1547-52. 
 34.  Mobasheri A, Marples D. Expression of the AQP-1 water channel in normal 
human tissues: a semiquantitative study using tissue microarray technology. 
Am J Physiol Cell Physiol 2004; 286(3):C529-37. 
 35.  Trujillo E, Gonzalez T, Marin R, Martin-Vasallo P, Marples D, Mobasheri A. 
Human articular chondrocytes, synoviocytes and synovial microvessels 
 24
express aquaporin water channels; upregulation of AQP1 in rheumatoid 
arthritis. Histol Histopathol 2004; 19(2):435-44. 
 36.  Eiraku M, Hirata Y, Takeshima H, Hirano T, Kengaku M. Delta/notch-like 
epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-
containing protein targeted to dendrites of developing and adult central 
nervous system neurons. J Biol Chem 2002; 277(28):25400-7. 
   37.  Eiraku M, Tohgo A, Ono K, Kaneko M, Fujishima K, Hirano T et al. DNER acts 
as a neuron-specific Notch ligand during Bergmann glial development. Nat 
Neurosci 2005; 8(7):873-80. 
 38.  Hayes AJ, Dowthwaite GP, Webster SV, Archer CW. The distribution of Notch 
receptors and their ligands during articular cartilage development. J Anat 
2003; 202(6):495-502. 
 39.  Lublin DM, Atkinson JP. Decay-accelerating factor: biochemistry, molecular 
biology, and function. Annu Rev Immunol 1989; 7:35-58. 
 40.  Davies ME, Horner A, Loveland BE, McKenzie IF. Upregulation of complement 
regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint 
disease. Scand J Rheumatol 1994; 23(6):316-21. 
 41.  Tarkowski A, Trollmo C, Seifert PS, Hansson GK. Expression of decay-
accelerating factor on synovial lining cells in inflammatory and degenerative 
arthritides. Rheumatol Int 1992; 12(5):201-5. 
   42.   Gay S, Müller PK, Lemmen C, Remberger K, Matzen K, Kühn K. 
Immunohistological study on collagen in cartilage-bone metamorphosis and 
degenerative osteoarthrosis. Klin Wochenschr 1976; 54(20):969-76. 
   43.   Kühn B, del Monte F, Hajjar RJ, Chang Y-S, Lebeche D, Arab S et al. 
Periostin induces proliferation of differentiated cardiomyocytes and promotes 
cardiac repair. Nat. Med. 2007; 13(8):962-9. 
   44.   Williams FMK, Spector TD. Biomarkers in osteoarthritis. Arthritis Res Ther 
2008,10:101. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25
Tables 
 
Table 1: Primer sequences for qRT-PCR 
 
Gene pimer sequence amplicon size (bp) 
IGFBP-3 f 
r 
5’-TCT GCG TCA ACG CTA GTG C-3’ 
5’-GCT CTG AGA CTC GTA GTC AAC T-3’ 
245 
WISP-1 f 
r 
5’-CCA GCC TAA CTG CAA GTA CAA-3’ 
5’-GGC GTC GTC CTC ACA TAC C-3’ 
160 
AQP-1 f 
r 
5’-GGT GGG GAA CAA CCA GAC G-3’ 
5’-TAC ATG AGG GCA CGG AAG ATG-3’ 
177 
DNER f 
r 
5’-AAG GCT ATG AAG GTC CCA ACT-3’  
5’-CTG AGA GCG AGG CAG GAT TT-3’  
137 
DAF f 
r 
5’-CTT CCC CCA GAT GTA CCT AAT GC-3’ 
5’-CGC AGC TAC GAT TGC AGA ACT-3’  
184 
IF f 
r 
5’-TGG CAG GTG GCA ATT AAG GAT-3’  
5’-ACG ATG AGT TTT ACT GGC TCT G-3’  
111 
GAPDH f 
r 
5’-CTG ACT TCA ACA GCG ACA CC-3’ 
5’-CCC TGT TGC TGT AGC CAA AT-3’ 
120 
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Table 2: RNA yield and quality obtained by different isolation approaches. 
 
 Extraction procedure 
Mechanical pretreatment Trizol Qiagen Ambion
Polytron n. d. + n. d. 
Mortar and pestle n. d. + n. d. 
Mill deg. ++ +++ 
 
 
+ (low) <50 ng/µl, ++ (medium) 50-100 ng/µl, +++ (high) >100 ng/µl; n. d. = not 
determined, deg. = degraded. 
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Table 3: Genes identified to be up-regulated in all 5 patients (alphabetical order). 
 
Probe Set ID Gene name code mean SLR mean CPV 
209047_at aquaporin 1 (channel-forming integral protein, 28kDa) AQP1 1.38 0.0000948 
1555950_a_at 
decay accelerating factor for complement (CD55, Cromer blood 
group system) DAF 0.92 0.0000538 
226281_at delta-notch-like EGF repeat-containing transmembrane DNER 1.16 0.0000468 
203854_at I factor (complement) IF 1.14 0.0001440 
210095_s_at insulin-like growth factor binding protein 3 IGFBP3 1.60 0.0000440 
229802_at WNT1 inducible signaling pathway protein 1 WISP1 0.98 0.0000372 
 
SLR : Signal Log Ratio, CPV : Change p-value 
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Figures 
 
Figure 1: Swing mill (Microdismembrator) used for cartilage preparation (A). The 
individual cartilage tissue samples were pulverized with steels balls in steel cases (B) 
double-fixed in the mill (A) with a safety screw. The pre- (C) and post-pulverization 
(D) status is shown schematically. 
 
                               A  
 
                               B              
 
                               C                
                               D                 
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Figure 2: Graphical analysis of the RNA integrity on the Agilent 2100 Bioanalyzer. 
The electropherogram shows clear peaks for both 28S and 18S rRNA. Although 
there is a slight decrease in height of the 28S rRNA peak, RNA quality can be 
considered as high. 
 
                
18S 28S 
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Figure 3: Representative results of a quantitative RT-PCR. Intensity of differential 
expression is indicated as the logarithm base 2 of the fold change. RQ: relative 
quantification, equal to fold change. 
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Figure 4: Illustration of representative cartilage sections within the same joint of OA 
patients (original magnification x50). The first panel shows an intact area (left, A) and 
a diseased area (right, B) stained by hematoxylin-eosin. The second panel shows the 
lack of expression of AQP-1 in non-lesional areas of an OA patient (C, phase 
contrast D), whereas the majority of chondrocytes in the superficial zone of an OA 
lesion express intensively AQP-1 (↑, E, phase contrast F). Similarly, WISP-1 is  
expressed throughout the areas of cartilage erosions (↑, I and K), whereas in intact 
cartilage, no specific staining (G and H) can be detected. This is also visible for DAF. 
Here, an increased staining is to be observed in lesional areas (↑, N and O) in 
contrast to unaffected cartilage (L and M).  
Note that for WISP-1 (third panel, H and K) and DAF (fourth panel, M and O) 
counterstaining with Mayer’s hematoxylin was performed to detect the nuclei of the 
chondrocytes. The inserts in K and O show a larger image of single counter-stained 
chondrocytes expressing WISP-1 (K) and DAF (O), respectively. Black and white 
scale bars always indicate 100 µm. 
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